Cookies on VetMed Resource

Like most websites we use cookies. This is to ensure that we give you the best experience possible.

 

Continuing to use www.cabi.org  means you agree to our use of cookies. If you would like to, you can learn more about the cookies we use.

VetMed Resource

Veterinary information to support practice, based on evidence and continuing education

Sign up to receive our Veterinary & Animal Sciences e-newsletter, book alerts and offers direct to your inbox.

Results per page:

Search results

AbstractFull Text

Background: Vascular access port (VAP) was developed for the administration of chemotherapeutic agents, minimizing local drug reactions and complications associated with migration of peripheral venous catheter (PVC) in humans. The device is widely used in human oncology and has gained importance in ...

Author(s)
Souza Barni, B. de; Becerra, J. R. H.; Vidor, S. B.; Oliveira, M. P. de; Vieira, L. C.; Gnoatto, C. B.; Faria Valle, S. de; Gomes, C.; Gianotti, G. C.; Contesini, E. A.
Publisher
Universidade Federal do Rio Grande do Sul, Faculdade de Veterinária, Porto Alegre, Brazil
Citation
Acta Scientiae Veterinariae, 2020, 48, 1738,
Abstract

Canine osteosarcoma (OSA), the most common canine primary bone malignancy, has a highly aggressive biologic behavior. Despite current standard of care therapies, including amputation and adjuvant chemotherapy, most dogs still succumb to metastatic disease. Further investigations into molecular...

Author(s)
Baldanza, V. E.; Rogic, A.; Yan WeiWei; Levine, C. B.; Levine, R. A.; Miller, A. D.; McCeary-Wheeler, A. L.
Publisher
Public Library of Sciences (PLoS), San Francisco, USA
Citation
PLoS ONE, 2020, 15, 4,
Abstract

Literature describing medical treatment of canine prostatic carcinoma (PC) is sparse. The aims of this study were to assess outcomes, including time to progression (TTP) and median survival time (MST), of canine PC treated with non-steroidal anti-inflammatory drugs (NSAIDs) and/or chemotherapy, and ...

Author(s)
Ravicini, S.; Baines, S. J.; Taylor, A.; Amores-Fuster, I.; Mason, S. L.; Treggiari, E.
Publisher
Wiley, Oxford, UK
Citation
Veterinary and Comparative Oncology, 2018, 16, 4, pp 450-458
Abstract

Splenectomy followed by adjuvant chemotherapy is commonly used to treat canine splenic haemangiosarcoma (HSA), although it is unclear if different treatment protocols may have a similar efficacy. The objective of this retrospective study was to assess outcome in dogs with stage I and II splenic HSA ...

Author(s)
Treggiari, E.; Borrego, J. F.; Gramer, I.; Valenti, P.; Harper, A.; Finotello, R.; Toni, C.; Laomedonte, P.; Romanelli, G.
Publisher
Wiley, Oxford, UK
Citation
Veterinary and Comparative Oncology, 2020, 18, 1, pp 43-51
Abstract

Few veterinary studies have evaluated the response to chemotherapy treatment of canine intranasal tumours, while many have focused on the efficacy of radiation therapy. Given the higher costs and limited access to radiation therapy, alternative treatment options are needed. The study describes a...

Author(s)
Woodruff, M. J.; Heading, K. L.; Bennett, P.
Publisher
Wiley, Oxford, UK
Citation
Veterinary and Comparative Oncology, 2019, 17, 1, pp 42-48
Abstract

Background: The rapid growth in off-leash dog parks provides opportunity for canine socialization activities but carries risk of exposure to intestinal parasites. This study assessed the prevalence of these infections in dogs visiting off-leash dog parks. Methods: Fresh defecations were collected...

Author(s)
Stafford, K.; Kollasch, T. M.; Duncan, K. T.; Horr, S.; Goddu, T.; Heinz-Loomer, C.; Rumschlag, A. J.; Ryan, W. G.; Sweet, S.; Little, S. E.
Publisher
BioMed Central Ltd, London, UK
Citation
Parasites and Vectors, 2020, 13, 275, pp (01 June 2020)
Abstract

Objectives: To determine whether the addition of metronomic chemotherapy improved outcome for dogs with splenic haemangiosarcoma treated with splenectomy and adjuvant maximum tolerated dose chemotherapy. Materials and methods: Medical records were examined retrospectively for dogs with splenic...

Author(s)
Alexander, C. K.; Cronin, K. L.; Silver, M.; Gardner, H. L.; London, C.
Publisher
Wiley, Oxford, UK
Citation
Journal of Small Animal Practice, 2019, 60, 1, pp 32-37
AbstractFull Text

Canine osteosarcoma is an agressive tumour that has both a locally invasive and highly metastatic biologic behavior. Osteosarcoma is the most important primary bone tumour in dogs, being the most common. Usually, it's occurrence is in the appendicular skeleton and the most frequently involved are...

Author(s)
Alexandru, D. M.; Dobre, I. R.; Crivineanu, M.
Publisher
University of Agronomic Sciences and Veterinary Medicine of Bucharest, Bucharest, Romania
Citation
Scientific Works. Series C. Veterinary Medicine, 2020, 66, 1, pp 25-29
Abstract

Background: Myxosarcomas are known to be classified as soft tissue sarcomas. However, there is limited clinical characterization pertaining specifically to canine cutaneous myxosarcomas in the literature. The objective of this study is to evaluate the local recurrence rate, metastatic rate and...

Author(s)
Iwaki, Y.; Lindley, S.; Smith, A.; Curran, K. M.; Looper, J.
Publisher
BioMed Central Ltd, London, UK
Citation
BMC Veterinary Research, 2019, 15, 217, pp (27 June 2019)
Abstract

No standard of care is currently recognized for treatment of canine prostatic carcinoma (PC). This retrospective study assesses outcome following definitive-intent, intensity-modulated radiation therapy (RT) in dogs with PC. Medical records review was performed, including 18 patients from four...

Author(s)
Walz, J. Z.; Desai, N.; Asselt, N. van; Poirier, V. J.; Hansen, K.; Selmic, L.
Publisher
Wiley, Oxford, UK
Citation
Veterinary and Comparative Oncology, 2020, 18, 3, pp 381-388

Refine Results

Sort Order
Author
Geographical Location
Item Type
Language
Organisms
Subject Topics